Life Sciences & Biotechnology

Icon for Expertise Life Sciences and BIotechnology

Innovation in life sciences and biotechnology moves fast – and the intellectual property strategies protecting that innovation must keep pace.

Life Sciences & Biotechnology banner
Life Sciences & Biotechnology banner

Our Life Sciences & Biotechnology team combines significant scientific training with extensive patent and IP protection experience to help researchers, innovators and organisations safeguard their discoveries and maximise commercial value.

We translate complex science into robust IP protection, giving you the confidence that your ideas are understood, protected and positioned for growth.

Our team includes highly qualified and experienced attorneys and lawyers who also have significant research or industry experience. Our team of patent and trade marks attorneys each hold an undergraduate degree in science. In addition, many of our attorneys in this team hold Masters degrees in intellectual property law, some hold a Masters degree in commercial law, and most hold PhDs in disciplines including immunology, genetics, molecular cell biology, chemistry and nanotechnology.

Our clients include leading universities and research institutions, ASX-listed companies, multinational corporates, SMEs, start-ups and sole inventors. We are also regularly engaged by foreign corporates and overseas attorneys seeking trusted representation for patent filings in Australia, New Zealand and Southeast Asia.

Our attorneys are known for being highly responsive and easy to work with. We tailor every protection strategy to your commercial objectives, delivering technically accurate and commercially astute IP solutions. Our depth of expertise enables us to anticipate challenges, navigate regulatory landscapes and provide advice that holds up in practice – not just on paper.

We ensure that the right attorney, lawyer or team is matched to any given project. By emphasising teamwork across technologies, we create shared objectives and deliver solutions that support your broader commercial goals. This inclusive approach ensures our work is tailored to meet your commercial objectives.

Our strong expertise in patent litigation, further informs and strengthens our drafting and prosecution practices, providing strategic advice across all stages of IP protection.

As one of the few firms with a large internal litigation team, commercial law team and an experienced in-house IP research team, we can manage oppositions, litigation and complex searches entirely in-house – providing a streamlined, efficient and consistent service.

Our attorneys remain deeply engaged with the scientific community. They routinely read leading journals, attend industry conferences and stay across emerging research developments. This genuine scientific curiosity ensures your invention is met with informed interest and understanding of its technical nuances – because our attorneys are scientists too.

Technology fields

  • Biologics and small molecule pharmaceuticals
  • Gene and cell therapies
  • Genetics, genomics and molecular biology
  • Diagnostics and molecular testing
  • Vaccines and immunotherapies
  • Microbiome and microbial technologies
  • Bioprocessing and manufacturing technologies
  • Agriculture and AgTech innovations
  • Transgenic and genetically modified organisms
  • Functional polymers

Key Contacts

Mark Wickham headshot

Dr Mark Wickham

Principal
Melbourne
Danielle Burns headshot

Dr Danielle Burns

Principal
Melbourne
Scott Whitmore headshot

Dr Scott Whitmore

Principal
Adelaide
Christina Lucato headshot

Dr Christina Lucato

Patent & Trade Marks Attorney
Melbourne

Related news and insights

Trade Marks in FemTech: Building Brand Trust in Women’s Health banner

Trade Marks in FemTech: Building Brand Trust in Women’s Health

Trade marks play a key role in protecting that brand and securing a stronger market position as new products and services enter the market.
Jacqueline Leong

18 March 2026

Insights Photo

Otsuka Update: Special Leave Filed and IP Australia Refines PTE Processing Approach

The patentee has filed a special leave application to the High Court of Australia seeking to appeal the Full Court’s decision in Otsuka Pharmaceutical Co., Ltd v Sun Pharma ANZ Pty Ltd.
Dr Annabella Newton

4 March 2026

Insights Photo

Has the balance shifted? Federal Court grants first preliminary injunctions to pharmaceutical patentees since 2018

Two recent decisions of the Federal Court, AstraZeneca AB v Pharmacor Pty Ltd [2026] FCA 88 and Janssen Pharmaceutica NV v Juno Pharmaceuticals Pty Ltd [2025] FCA 1538 suggest the tide may be turning back to originators seeking preliminary injunctions (PIs) to restrain generic market entry.
Dr Christina Lucato

26 February 2026

View related

Discover our service and expertise areas, and our capability in other key sectors.

Learn more about what matters to our people

We are a curious and approachable team of professionals, united by a passion for IP and helping your ideas succeed.

Banner image
How can we help you?